# A Challenging Diagnostic Process: A Case of Lewy Body Dementia in Long-Standing Schizophrenia

**Authors:** Aslam Iqbal, Mohamed Alarayedh, Tahir Iqbal, Samuel Olugbuyi, Claire Hicks-Walsh

PMC · DOI: 10.7759/cureus.89967 · 2025-08-13

## TL;DR

This case report describes the diagnostic challenges of identifying Lewy Body Dementia in a patient with long-standing schizophrenia.

## Contribution

The paper emphasizes the importance of re-evaluating diagnoses in psychiatric patients to avoid misattribution of new symptoms.

## Key findings

- New symptoms in a patient with chronic schizophrenia were indicative of Lewy Body Dementia.
- Diagnostic overshadowing and anchoring bias can hinder accurate diagnosis in such cases.
- Periodic reassessment is crucial for appropriate management of evolving neurodegenerative conditions.

## Abstract

Lewy body dementia (LBD) is a progressive neurodegenerative disorder presenting with a wide range of cognitive, sleep, neuropsychiatric, motor, and autonomic symptoms. Diagnosing LBD in individuals with established psychiatric conditions, particularly chronic schizophrenia, presents significant challenges due to overlapping clinical features.

This case report outlines a case of a 78-year-old woman with a 48-year history of paranoid schizophrenia, who on her last admission exhibited new behavioural and functional decline. This included increased agitation, incoherent mumbling, visual hallucinations, self-harming behaviour, motor symptoms, and reduced responsiveness. Over time, she became increasingly frail and was displaying signs of extrapyramidal side effects on therapeutic doses of haloperidol.

Her presentation triggered regular comprehensive multidisciplinary team (MDT) discussions and reassessments, especially when the medical staff noted worsening motor symptoms, hypersensitivity to antipsychotics, and cognitive fluctuations. Although her primary psychiatric diagnosis had been schizophrenia for nearly five decades, the clinical evolution strongly indicated LBD, an emerging neurodegenerative process. Despite the absence of radiologic evidence, largely due to her condition, her new symptoms aligned with the diagnostic criteria for LBD. Subsequently, due to her poor physiological reserve, she was managed under a palliative care pathway.

This case highlights the importance of periodic diagnostic reassessment in a patient with a long-standing psychiatric disorder. Without careful review, there is a risk of diagnostic overshadowing, where new symptoms observed are miscredited to a historical diagnosis. Additionally, anchoring bias can further add to the issue as clinicians become fixated on the initial diagnosis. As a result, differentiating between chronic psychosis and evolving neurodegenerative conditions like LBD is crucial to avoid inaccurate management and to develop appropriate care plans, especially in vulnerable patients.

## Linked entities

- **Chemicals:** haloperidol (PubChem CID 3559)
- **Diseases:** Lewy Body Dementia (MONDO:0007488), schizophrenia (MONDO:0005090)

## Full-text entities

- **Genes:** SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}
- **Diseases:** Schizophrenia (MESH:D012559), hypersensitivity (MESH:D004342), tremors (MESH:D014202), disrupted sleep (MESH:D019958), death (MESH:D003643), III (MESH:C537189), cognitive decline (MESH:D003072), balance problems (MESH:D019973), paranoid schizophrenia (MESH:D012563), neurodegenerative (MESH:D019636), depression (MESH:D003866), thrombosis (MESH:D013927), chronic (MESH:D002908), faecal incontinence (MESH:D014549), learning disability (MESH:D007859), rapid eye movement (REM) sleep disturbances (MESH:D020187), abdominal discomfort (MESH:D000007), delusions (MESH:D063726), dysphagia (MESH:D003680), gallstones (MESH:D042882), muscle stiffness (MESH:D019042), NMS (MESH:D009459), mental disorder (MESH:D001523), pain (MESH:D010146), hypertension (MESH:D006973), rigidity (MESH:D009127), anxiety (MESH:D001007), psychosis (MESH:D011618), gastrointestinal bleeding (MESH:D006471), thought disorder (MESH:D009358), gallstone disease (MESH:D002769), agitation (MESH:D011595), autonomic dysfunction (MESH:D001342), LBD (MESH:D020961), orthostatic hypotension (MESH:D007024), postural instability (MESH:D054972), bruises (MESH:D003288), chronic kidney disease (MESH:D051436), confusion (MESH:D003221), Parkinson-like movement (MESH:D010302), rectal bleeding (MESH:D012002), catatonia (MESH:D002389), dementia (MESH:D003704), REM (MESH:D020923), auditory hallucination (MESH:D006212)
- **Chemicals:** fluphenazine (MESH:D005476), promethazine (MESH:D011398), Buprenorphine (MESH:D002047), Lorazepam (MESH:D008140), rivastigmine (MESH:D000068836), procyclidine (MESH:D011352), Olanzapine (MESH:D000077152), diazepam (MESH:D003975), haloperidol (MESH:D006220)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12344741